조마 코퍼레이션(XOMA)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $40.17 (-9.16%), 시가총액 $0.52B, PER (주가수익비율) 26.46, 52주 최저~최고 $22.89 ~ $42.00.
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty
조마 코퍼레이션의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
조마 코퍼레이션의 현재 주가는 $40.17 (-9.16%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
조마 코퍼레이션의 시가총액은 약 $0.52B입니다. PER은 26.46입니다.
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential mileston